Wells Fargo & Company Chembio Diagnostics, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.25 - $0.45 $58 - $105	-235 Reduced 9.46%	2,250 $0
Q4 2022 Feb 13, 2023	BUY	$0.2 - $0.33 $209 - $345	1,046 Added 72.69%	2,485 $0
Q3 2022 Nov 14, 2022	SELL	$0.35 - $1.1 $0 - $1	-1 Reduced 0.07%	1,439 $0
Q2 2022 Aug 12, 2022	BUY	$0.45 - $0.8 $7 - $12	16 Added 1.12%	1,440 $1,000
Q1 2022 May 16, 2022	BUY	$0.66 - $1.23 $0 - $1	1 Added 0.07%	1,424 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $17,431 - $40,779	-15,992 Reduced 91.83%	1,423 $1,000
Q3 2021 Nov 15, 2021	BUY	$2.06 - $5.34 $33,067 - $85,717	16,052 Added 1177.7%	17,415 $43,000
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $30,147 - $59,039	-10,468 Reduced 88.48%	1,363 $4,000
Q1 2021 May 13, 2021	SELL	$3.4 - $7.97 $86,373 - $202,469	-25,404 Reduced 68.23%	11,831 $41,000
Q4 2020 Feb 09, 2021	BUY	$4.11 - $7.51 $17,927 - $32,758	4,362 Added 13.27%	37,235 $177,000
Q3 2020 Nov 05, 2020	SELL	$3.28 - $5.93 $19,834 - $35,858	-6,047 Reduced 15.54%	32,873 $159,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $23,277 - $113,752	7,320 Added 23.16%	38,920 $127,000
Q1 2020 May 14, 2020	BUY	$2.36 - $5.6 $74,576 - $176,960	31,600 New	31,600 $162,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.